Thursday, December 25, 2025
Home Authors Posts by Ogkologos

Ogkologos

4104 POSTS 0 COMMENTS

Nivolumab Plus Ipilimumab Demonstrates Long-Term Survival Benefit in Patients with Advanced...

Ogkologos -
0

Adding 24 Months of ADT Improves Metastasis-Free Survival in Patients with...

Ogkologos -
0

FDA Grants Accelerated Approval to Tarlatamab-dlle for Extensive Stage Small Cell...

Ogkologos -
0

Neoadjuvant Dabrafenib Plus Trametinib Has High Pathological Response Rates in Clinical...

Ogkologos -
0

EMA Recommends Extension of Indications for Alectinib to Adjuvant Treatment of...

Ogkologos -
0

Perioperative Treatment with Nivolumab Results in Significantly Longer Event-Free Survival than...

Ogkologos -
0

Pembrolizumab Provides First-Ever Overall Survival Improvement in Kidney Cancer

Ogkologos -
0

Biomarker Analyses in Patients with HER2-positive or HER2-low Gastric and Gastro-oesophageal...

Ogkologos -
0

EMA Recommends Extension of Indications for Nivolumab to Include First-Line Treatment...

Ogkologos -
0

Evaluation of Pemigatinib Efficacy in FGFR-Altered Advanced Solid Tumours Led to...

Ogkologos -
0
1...525354...411Page 53 of 411

MOST POPULAR

Load more

HOT NEWS

Follow us on Instagram @ogkologos

Το πρώτο ολοκληρωμένο portal για τον καρκίνο. Ενημερωθείτε για τον καρκίνο, καθώς και για τις τελευταίες εξελίξεις.
Contact us: info@ogkologos.com

POPULAR POSTS

POPULAR CATEGORY

Copyright © 2023 Ogkologos.com